1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TET3 CTRPv2 pan-cancer AAC 0.2 1e-07
mRNA ADNP2 CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA SNAP25 CTRPv2 pan-cancer AAC 0.2 1e-07
mRNA KCNB2 CTRPv2 pan-cancer AAC 0.18 1e-07
mRNA GIGYF1 CTRPv2 pan-cancer AAC 0.2 1e-07
mRNA ZIK1 CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA CERKL CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA RNF183 CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA AGO4 CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA ARHGAP45 CTRPv2 pan-cancer AAC 0.26 2e-07
Download CSV